å°ä¿æ¹æ´åæ°ãçºè¦ãããSTAPç¾è±¡ãããã¢ã¡ãªã«ã®ç 究è ã°ã«ã¼ãã«ãã£ã¦å ±åããã¦ããã2015å¹´11æ27æ¥ã«è±å½ç§å¦éèªããã¤ãã£ã¼ãå§å¦¹çã®ãªã¼ãã³ã¢ã¯ã»ã¹ã¸ã£ã¼ãã«ããã¤ãã£ã¼ã»ãµã¤ã¨ã³ãã£ããã¯ã»ãªãã¼ããã«æ²è¼ãããã ããã¯ãç±³ãããµã¹å¤§å¦å»å¦é¨ãã¥ã¼ã¹ãã³æ ¡ã®ãã³ã¬ã»ã´ã©ã¤ãããå士ãããè² å·ãããã¦ã¹ã®éª¨æ ¼çãã幹細èã«ãªãæ°è¦ã®ç´°èéå£ãçºè¦ããã¨è«æã§çºè¡¨ãããã®ã ãé¡åã¯ãæå·èªå°æ§ã®çèç±æ¥å¹¹æ§ç´°èãã§è±æã®é æåãinjury induced muscle-derived stem cell-like cellsãããiMuSCsã¨åä»ããããããã証æãããã®ã¯ã´ã©ã¤ãããè«æã¨å¼ã°ãã¦ããããã³ã¬å士ã¯åè«æã®è¦æ¨ãããã¾ã¨ãã¦ããã ãæã ã¯æè¿ãæå·ãåãããã¦ã¹ã®éª¨æ ¼çã®ãªãã«ãæ°ãã幹細èã®éå£ãçºè¦ãã¾ããããã®iMuSCsã¯ãååããçåæ§ç´°è

{{#tags}}- {{label}}
{{/tags}}